Mesothelioma
Research
Mesothelioma Research
Mesothelioma is a disease that is still very
hard to recognise, difficult to diagnose and virtually impossible to treat
effectively. It is known that the disease is asbestos related and that there is
a long latency period before symptoms become apparent. But with more and more
cases coming to light each year, it is vital that further research is carried
out in order to make this fatal disease more manageable for both patients and
doctors.
Many organizations are involved in research
in to mesothelioma. This includes the companies that are responsible for the use
of asbestos. Many people that have been diagnosed with mesothelioma have
now discovered that they can claim compensation for being exposed to hazardous
asbestos by companies, which means that these companies have a responsibility to
help with this research.
The National Institute of Cancer is also
working hard to research mesothelioma, its symptoms, diagnosis and treatment.
The rising number of mesothelioma cases means that it is essential to
learn more about this disease in order to look into developing treatments.
With many mesothelioma patients now seeking
legal advice, it has become essential for law firms to learn about and research
the disease. It is the lawyer’s job to assist the mesothelioma patient
and provide advice and resources from which the patient can get help and
assistance. Therefore, law firms dealing with these types of cases also have a
responsibility to learn about the disease and what can be done to help patients.
A great deal of research into mesothelioma
goes into learning about the effects of asbestos upon cells, and how the cells
are changed by exposure to this material. By learning how healthy cells and
corrupted by asbestos, we hope to learn more about how this cell corruption can
be prevented or minimised.
The National Institute of Cancer has also
carried out clinical trials into the treatment of mesothelioma. The
trials, which are performed with real patients who have been diagnosed with
mesothelioma, should help to determine how effective the various
treatments are, and hopefully will go some way to helping experts find more
effective treatments for the disease.
Mesothelioma trials are based upon
treatments that are thought to have some value to patients. But the trials are
just that – trials. This means that there are no guarantees and that a great
deal more work and research will be required before a conclusive and effective
treatment is found. On the upside, many new trials are being carried out on a
regular basis, and with the information and technology available to scientists
today, the discovery of an effective treatment for mesothelioma patients
is just a matter of time.
Medical professionals worldwide are
currently involved in clinical trials, and each trial depends upon the extent of
spread of the disease. Some trials are performed on those who have been
diagnosed reasonably early, others on patients who were not diagnosed until the
latter stages of the disease. It is important for scientists to find a treatment
that is effective not only on those who are diagnosed early, but on all patients
that suffer from this killer disease.
The research carried out into mesothelioma
will hopefully mean that future generations of suffers can be saved, even if
they are diagnosed with the disease. The research carried out is extremely
costly, and is often sponsored by associated companies such as drug companies
and research groups as well as by the government. Research into the contraction
of the disease, and its subsequent development will ultimately enable
professionals to devise the most effective treatment.
Several new methods of treatment have been
used following research into mesothelioma. These include:
Photodynamic therapy, which uses fixed frequency light to target
abnormal cells and kill them off by the activation of photosensitizing drugs.
Immunotherapy, which fights the abnormal cells through the use of
the body’s own defence system through enhancement and development of the immune
system.
Intensity Modulated Radiation Therapy, which is a radiation treatment that
targets just the affected area/tumour, thus avoiding contact with healthy cells
and tissue.
Although there is no quick-fix answer to the treatment of mesothelioma,
ongoing research and dedication from the medical profession means that the
chances of finding an effective treatment are continually increasing.